Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

about

Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.Study on the activity and mechanism of skimmianine against human non-small cell lung cancer.

P2860

Q38729973-3C637FBE-5D65-4C7F-B008-79A7B1F61E4E Q47351178-D7966926-9FE3-44B9-A9C8-CBFFE8A9C2F3

P2860

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

Item

http://www.wikidata.org/entity/Q36273796

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

@ast

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

@en

type

Item

label

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

@ast

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

@en

prefLabel

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

@ast

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

@en

P1476

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

@en

P2093

Matthew Trendowski

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

PI3K/AKT/mTOR Pathway in Angiogenesis

Production of novel rapamycin analogs by precursor-directed biosynthesis.

Cleavage behavior of calicheamicin gamma 1 and calicheamicin T

Chemistry and biology of natural and designed enediynes

Interleukin-2 receptor signaling: at the interface between tolerance and immunity

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability

Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma

Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer

The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin

P2888

s40265-015-0489-4

P304

1993-2016

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40265-015-0489-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283260236

http://www.w3.org/2001/XMLSchema#string

P698

26501980

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

4642600

http://www.w3.org/2001/XMLSchema#string

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

about

P2860

P2860

Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932